Bipolar II Disorder: Characterized by Hypomania and Depression
Bipolar II disorder is characterized by episodes of hypomania and depression, without any full manic or mixed manic episodes. 1 This specific subtype of bipolar disorder is defined by the presence of at least one hypomanic episode and one or more major depressive episodes in a person's lifetime.
Diagnostic Criteria for Bipolar II Disorder
Hypomania Criteria
- Episodes lasting at least 4 days (minimum duration requirement) 1
- Elevated (euphoric) and/or irritable mood 2
- At least three of the following symptoms (four if mood is only irritable):
- Grandiosity
- Decreased need for sleep without feeling tired
- Increased talking/pressured speech
- Racing thoughts/flight of ideas
- Distractibility
- Increased goal-directed activity/overactivity
- Psychomotor agitation
- Excessive involvement in risky activities 2
Key Distinctions from Bipolar I Disorder
- No history of full manic or mixed episodes 3
- Hypomanic episodes are not severe enough to:
- Hypomania may actually increase functioning in some cases, making the distinction between mania and hypomania clearer 2
Depressive Features
- Depression is often the prominent feature of Bipolar II disorder 2
- Depressive episodes typically outnumber hypomanic episodes by a ratio of 39:1 3
- Depressive episodes may include:
- Psychomotor retardation
- Hypersomnia
- Significant suicide risk
- Psychotic symptoms (more common than in unipolar depression) 4
- Often presents as "mixed depression" with concurrent, usually subsyndromal, hypomanic symptoms 2
Clinical Significance and Challenges
Prevalence and Underdiagnosis
- While DSM-IV reported a lifetime community prevalence of 0.5%, epidemiological studies have found a lifetime community prevalence of around 5% (including the bipolar spectrum) 2
- In depressed outpatients, as many as one in two may have Bipolar II disorder 2
- Commonly misdiagnosed as major depressive disorder and treated with antidepressant monotherapy, which may worsen prognosis 3
Severity and Impact
- Although often perceived as a less severe form of bipolar disorder, evidence suggests significant functional and cognitive impairment 3
- Associated with elevated risk of suicidal behavior, with rates of completed suicide at least equivalent to Bipolar I disorder 3
- Life expectancy is reduced by 12-14 years in individuals with bipolar disorder 4
- 1.6-2 fold increased risk of cardiovascular mortality 4
Treatment Considerations
Pharmacotherapy
- Treatment guidelines for Bipolar II are often extrapolated from Bipolar I research 3
- For hypomania:
- Likely to respond to same agents useful for mania
- Mood-stabilizing agents such as lithium and valproate
- Second-generation antipsychotics (olanzapine, quetiapine, risperidone, ziprasidone, aripiprazole) 2
- For depression:
Important Treatment Considerations
- Hypomania should be treated even if associated with overfunctioning, as depression often soon follows (hypomania-depression cycle) 2
- Debate continues over whether antidepressants should be used as monotherapy or in combination with mood stabilizers for Bipolar II depression 5
- Antidepressants may worsen concurrent intradepression hypomanic symptoms in mixed depression 2
Common Pitfalls in Diagnosis and Management
- Misdiagnosis as unipolar depression: The most common diagnostic error, leading to inappropriate treatment with antidepressant monotherapy
- Overlooking hypomanic episodes: Patients often don't report hypomanic episodes as they may be perceived as positive experiences or periods of normal functioning
- Failure to recognize mixed features: Depression with mixed features (subsyndromal hypomanic symptoms) is common in Bipolar II and requires different treatment approaches
- Underestimating suicide risk: Despite being considered "less severe" than Bipolar I, Bipolar II carries a significant suicide risk that should not be underestimated
In summary, Bipolar II disorder represents a distinct clinical entity characterized by recurrent episodes of hypomania and depression, with significant implications for diagnosis and treatment. Early recognition and appropriate management are crucial to improve outcomes and reduce the substantial morbidity and mortality associated with this condition.